Part of the classic RSI, thiopentone is one of the induction agents you’re most likely going to use for the first time in a crisis. Since it is seldom used anymore except in maternity or by old-school consultants, its worth knowing reasonably well.
It has some genuinely neat chemistry—thiopentone shows tautomerism and switches between a water-soluble isomer when in the vial to a lipid soluble isomer in the body.
Class and Use
Class: Thiobarbiturate
Use: Intravenous induction agent for anaesthesia
Special uses
- Anticonvulsant: used in refractory status epilepticus
- Neuroprotection: high-dose thiopental can be used to induce burst suppression for neuroprotection in high ICP or neurosurgery
- Pregnancy: used in RSI of pregnancy
Presentation and dose
Storage / preparation
Supplied as dry powder with sodium carbonate
It is a racemic mixture (of R and S enantiomers) and exhibits tautomerism
Tautomerism: thiopentone exists in its water-soluble enol form in alkaline solution, but shifts to its lipid-soluble keto form at physiological pH
Reconstitution: 500 mg sodium thiopental powder + 20 mL water → 25 mg/mL solution
Presentation
It is presented as a sodium salt → this makes it water-soluble but very alkaline (pH ~10.5–11).
This means, unlike propofol, its bacteriostatic
However, because it’s so alkaline, it’s dangerous if extravasated or injected intra-arterially
Dose
Standard IV induction dose is 3-7mg/kg
Mechanism of Action
GABA-A receptor modulation
Thiopental is a positive allosteric modulator at the GABA-A receptor
It increases the duration of chloride (Cl⁻) channel opening
↑ Cl⁻ influx → neuronal hyperpolarisation
reduced neuronal excitability and sedation
At high doses, it can directly activate the GABA-A receptor
Pharmacokinetics
Absorption
Given IV – 100% bioavailability
Distribution
pKa 7.6: so approx ~60% unionised at pH 7.4 → allowing rapid CNS penetration
Exists in its highly lipid-soluble keto form at physiological pH
Protein binding: 80–85%
Vd: ~2–3.5 L/kg
Offset is due to redistribution (CNS → muscle and fat), not metabolism
Metabolism
Hepatic metabolism via CYP450 → to active and inactive metabolites
includes pentobarbital (an active oxybarbiturate metabolite)
Enzyme inducer (↑ CYP450 after single dose)
Zero-order kinetics possible at high plasma levels → due to saturation of metabolic pathways (not suitable for TIVA)
Excretion
Renally excreted
Clearance: ~3.5 mL/kg/min
Pharmacodynamics: effects and side-effects by system
Respiratory
Dose-dependent depression → often apnoea
May cause laryngospasm or bronchospasm
Cardiovascular
↓ CO, ↓ SV, ↓ SVR (causing ↓ BP)
Baroreceptor reflex preserved → ↑ HR (compensatory tachycardia secondary to ↓BP)
Neurological
Rapid induction of anaesthesia in one arm brain time
↓ CMRO₂, ↓ CBF, ↓ ICP, ↓ IOP
Anticonvulsant: used in status epilepticus
- High-dose thiopentone can cause burst supression on EEG (which is useful in neuroprotection e.g. ↑ ICP)
Miscellaneous
Can cause tissue necrosis if extravasated (due to high pH)
Absolutely contraindicated in porphyria (as it induces ALA synthase → may trigger acute attack)
~1 in 20,000 risk of anaphylaxis
- Intra-arterial injection causes → vasospasm, thrombosis, necrosis
Intra-arterial Injection
We know by now that thiopental is supplied as a highly alkaline solution (pH ≈ 10.5–11) to make it water-soluble.
And once injected, at a physiological pH, the sodium thiopental solution converts back to its weakly soluble, unionised (ketone) form, which is poorly soluble in water
The result is:
Thiopental precipitates out as crystals in the arterial lumen
Crystals physically obstruct the vessel lumen and damage the endothelium
In addition, the alkaline pH itself is irritant and caustic, causing chemical injury to the intima
This initiates vasospasm and thrombus formation at the site
So why doesn’t this happen in venous injection?
Intravenously, thiopental mixes gradually with venous blood, allowing time for:
Dilution
Buffering by plasma proteins
Distribution before precipitation occurs
If any crystals do form, they are diluted and can re-dissolve within the high-volume venous circulation before reaching small arteries and causing spasm/occlusion
Management of intra-arterial injection
Stop injection
High-volume saline dilution
Intra-arterial vasodilators: papaverine, procaine
Consider sympathetic block (e.g. stellate gangion block) to promote vasodilation